跳至主要内容
临床试验/NCT05681234
NCT05681234已完成不适用

Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma

Affiliated Hospital of Jiangnan University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年8月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
Evaluation of tissue distribution of 18F-RD2

研究概览

简要总结

This is a single arm study to evaluate the safety and biodistribution of 18F-labeled RD2 PET/CT Imaging in patients with small liver carcinoma.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with highly suspected tumor;
  • Patients underwent PET/CT examination within 1 week;
  • Patients voluntarily signed informed consent;
  • Over 18 years old, male or female.

排除标准

  • Pregnant women;
  • Lactating women;
  • Patients with impaired renal function.

结局指标

主要结局

Evaluation of tissue distribution of 18F-RD2

时间窗: 2 hours

Biodistribution of 18F-RD2 evaluated by radioactive uptake values (standardized uptake values, SUVs) in various organs during repeated 18F-RD2 scans will be reported.

次要结局

未报告次要终点

研究者

发起方
Affiliated Hospital of Jiangnan University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Chunjing Yu

Director

Affiliated Hospital of Jiangnan University

研究点 (1)

Loading locations...

相似试验